The human Fc3,RI (CD64) is a high a~nity receptor for the Fc portion of immunoglobulin (Ig), and its constitutively low expression on the cell surface of monocyte/macrophage and neutrophils is selectively upregulated by interferon 3' (IFN-3') treatment (Perussia, B., E. T. Dayton, R. Lazarus, V. Fanning, and G. Trinchieri. 1983 J. Biol. Chem. 266:13449). We describe the characterization a second gene (Fc3,RIb) that has a termination codon in the third extracellular domain and therefore predicts a soluble form of the receptor. We also define two distinct IFN-3'-responsive regions in the 5' flanking sequence of Fc3,RIb that resemble motifs that have been defined in the class II major histocompatibility complex promoter. The Fc3,RIb promoter does not possess canonical TATA or CCAAT boxes, but does possess a palindromic motif that closely resembles the initiator sequence identified in the terminal deoxynucleotidyl transferase/human leukocyte IFN/adeno-associated virus type II P5 gene promoters (Smale, S. T., and D. Baltimore. 1989 T reatment of mammalian cells with species specific IFNs (c~, ~, and 3,) induces shared and distinct cellular responses that result from induction or repression of selected genes (1). IFN-ol and -~ are products of all cells, share a common receptor, and exert similar effects on cells. IFN-3,, a product of activated T cells and NK cells, has a distinct cell surface receptor and induces unique effects as well as responses shared with IFN-ol and -~/(reviewed in reference 2). In vitro and in vivo administration of IFN-3, indicates that its predominant physiological role is to modulate immune functions. In particular, IFN-3,, but not IFN-or and -B, induces monocyte differentiation, and IFN-3, is the predominant macrophageactivating factor (3, 4). As such, myeloid cells must have sets of genes whose expression is regulated in response to IFN-3, treatment. The net effect of these IFN-3,-dependent pleiotypic changes is that the treated phagocytes display an activated phenotype (5). Macrophages activated by IFN-y treatment downregulate mannose receptors and collagenase secretion, and upregulate expression of components of the NADPH oxidase, IL-1, I1,-8, TNF, IP10, monokine induced by IFN-3, (MIG), 1 the MHC class I and II antigens, and Fc receptors (6-13).
T reatment of mammalian cells with species specific IFNs (c~, ~, and 3,) induces shared and distinct cellular responses that result from induction or repression of selected genes (1) . IFN-ol and -~ are products of all cells, share a common receptor, and exert similar effects on cells. IFN-3,, a product of activated T cells and NK cells, has a distinct cell surface receptor and induces unique effects as well as responses shared with IFN-ol and -~/(reviewed in reference 2). In vitro and in vivo administration of IFN-3, indicates that its predominant physiological role is to modulate immune functions. In particular, IFN-3,, but not IFN-or and -B, induces monocyte differentiation, and IFN-3, is the predominant macrophageactivating factor (3, 4) . As such, myeloid cells must have sets of genes whose expression is regulated in response to IFN-3, treatment. The net effect of these IFN-3,-dependent pleiotypic changes is that the treated phagocytes display an activated phenotype (5) . Macrophages activated by IFN-y treatment downregulate mannose receptors and collagenase secretion, and upregulate expression of components of the NADPH oxidase, IL-1, I1,-8, TNF, IP10, monokine induced by IFN-3, (MIG), 1 the MHC class I and II antigens, and Fc receptors (6) (7) (8) (9) (10) (11) (12) (13) .
Responses of genes that are regulated by IFN-ct/~ appear to be mediated by a conserved motif, termed the IFNstimulated response element (ISRE), located within their regulatory regions (1, 4, 14, 15) . Interestingly, transcriptional upregulation of genes containing the ISRE by IFN-ol/B are augmented by IFN-3,. ISGF3 is a positive multimeric transactivating factor that targets the ISRE by translocating independent subunits from the cytoplasm to the nucleus upon IFN-c~ treatment. One component, ISGP33,, appears essen-1 Abbreviations used in this paper: ISRE, IFN-stimulated response element; tial for DNA binding and its synthesis is upregulated after treatment with IFN-3' (16) . Although less well characterized, a similar complex interaction between multiple factors is likely to account for the transcriptional control of genes that are exclusively upregulated by IFN-3,. The best studied of these genes are the MHC class II genes whose promoters contain a series of conserved c/s-acting elements termed X, Y, and H box and IFN-3' response element (3,-IRE) (reviewed in reference 17). A number of independent studies indicate that IFN-y responsiveness of this region cannot be accounted for by a DNA binding protein with one precise element. Our focus is to examine the regions that determine IFN-3' responsiveness in the context of a myeloid cell so as to gain insight into the molecular mechanisms that underlie the role of IFN-3, as a macrophage-activating factor. To this end, the regulation of the human Fc3~R.I gene is an attractive candidate as its expression is restricted to myeloid cells and is specifically upregulated by IFN-% IFN-y treatment alone results in a rapid increase in transcription of the Fc',/RI gene that results in up to a 20-fold induction of mRNA levels and expression of hundreds of thousands of cell surface receptors (reviewed in reference 18). The study of the regulation of the Fc"/RI gene should therefore provide insights into defining c/s-acting elements that confer myeloid specificity as well as definition of enhancers that target selective induction by IFN-3'.
Fc~RI is a member of a family of membrane receptors that recognize the Fc domain of Ig. The characterization of Fc receptors by molecular cloning has detailed a complex family of molecules that have a wide cellular distribution and a considerable structural heterogeneity that defines the diverse cellular responses triggered by ligation of Fc receptors (18) . Fc3,RI has a third Ig-like intracellular domain that determines its unique ability among Fc receptors to bind the monomeric Ig, and hence its designation as a high affinity Fc receptor, Three distinct cDNAs predict almost identical glycoproteins in their extracellular and transmembrane regions but differ in their cytoplasmic tails (19) . Recent reports have detailed the genomic organization of the FcyRI gene (20, 21) and provided evidence to support the existence of a second gene as defined by a difference in a HindIII restriction fragment length (20) .
In this study we provide a detailed analysis of the genomic organization of the putative second Fc'yRI gene (FcyRIb), which lacks HindlII in the second intron site due to a point mutation. In addition, a termination codon in the third extracellular domain and an insertion of a single amino acid appear to be the major points that distinguish this as a second gene. We have also mapped the regions in the Fc3rRI promoter that confer IFN-~/responsiveness and myeloid specificity. The c/s-acting dements share some homology with defined IFN-3, dements found in MHC class II promoters as well as having unique properties.
Materials and Methods
Cells and Cell Cultures. U937, THP-1, Raw 264.7, and Hela cells were obtained from the American Type Culture Collection (RockviUe, MD) and were maintained in RPMI supplemented with 10% FCS, 2 mM t-glutamine, 1 mM sodium pyruvate, and gentamycin (complete medium). All media and tissue cultures were scrupulously monitored to ensure endotoxin-free conditions. Isolation of tke 5' Flanking Region of the Fc~RI Gene. A human genomic library was screened by plaque hybridization using the 5' portion of Fc3'RI cDNA (-27 to +157; numbering from the ATG) as the probe. After prehybridization in 6 x SSC, 5 x Denhardt's, 0.1% SDS for 2 h at 68~ the random primed labeled probe (100,000 cpm/ml) was added and hybridization was performed at the same temperature for 12 h. Filters were washed serially in 2x SSC, 0.1% SDS for 30 min at 68~ with 0.2x SSC, 0.1% SDS for an additional 30 min at 68~ and with 0.2x SSC, 0.1% SDS for an additional 30 min at 68~ followed by autoradiography for 12 h. Positive plaques were picked and rescreened for an additional two rounds, after which DNA of the positive phages was prepared, restriction digested, and analyzed on Southern blot prehybridized in 6x SSC, 1 x Denhardt's, 0.5% SDS, 0.05% sodium pyrophosphate at 37~ for 1 h and hybridized at the same temperature for 12 h in the same solution containing 106 cpm/ml of a 5' end-labeled oligonucleotide primer (-7 to -26; representing the 5' end of the cDNA Cell Transfection. U937 or THP-1 cells were grown as suspension cultures in 250-ml flasks. 5 x 106 cells were transfected with 20/xg of DNA using the DEAE-dextran method (23) . Briefly, 40 /~g DNA was combined with 400/zg/ml of DEAE-dextran in a final volume of I ml of media containing 10% Nu-Serum. After 5 min at room temperature, the mixture was added to a 1-ml cell suspension (107 ceUs/ml) in media containing 10% Nu-Serum and incubated for 2 h at 37~ 5% CO2-air. The cells were then washed once in Dulbecco's PBS and shocked for 3 min in 10% DMSO in HBSS (5 mM KC1, 0.4 mM KH2PO4, 140 mM NaC1, 0.3 mM Na2HPO4-12H20, 5.5 mM glucose, 5 mM EDTA) at 37~ The DMSO was then diluted by addition of excess medium to the cells, washed twice with PBS followed by resuspension in 20 ml complete medium, and divided into two equal aliquots of 10 ml each. Each aliquot was then grown for 48 h at 37~ CO2-air before induction of one aliquot with 300 U/ml of recombinant human IFN-~/at 37~ for 12 h. The other aliquot served as the noninduced control. Hela and RAW 264.7 cells were plated at a density of 106 cells/100-mm petri dish on the evening before the day of transfection. The following morning each 100-ram dish was washed twice with PBS. Each dish was then incubated with a mixture of 20/zg DNA, 200/~g/ml DEAE-dextran in a final volume of 3.5 ml of RPM11640 containing 10% Nu-Serum. The dishes were incubated for 2-4 h at 37~
COrair. The monolayers were washed once with PBS and shocked for 3 rain at 37~ with 3 ml of 10% DMSO in HBSS. The DMSO was then diluted by an addition of excess medium to the cells, washed gently once with PBS, followed by an addition of excess medium to the cells, washed gently once with PBS, followed by an addition of 10 ml complete medium. The dishes were incubated overnight at 37~ CO2-air. Each dish was then split by limited trypsin-EDTA treatment and replated in two equal aliquots in 60-mm dishes and reincubated for an additional 24 h before stimulation of one subset with 300-400 U/ml of recombinant human or murine IFN-3~ for 12 h at 37~ The other subset served as the noninduced control.
CAT Assays. Cells were harvested and CAT assays were performed as follows. Adherent cells were washed three times with PBS and then incubated 5 rain at room temperature in I ml of TEN buffer (40 mM Tris-HC1 pH 7.5, 1 mM EDTA, 15 mM NAC1). The cells were then scraped off with a rubber policeman, and the suspension was spun in an Eppendorf microfuge for 10 rain at 4~ at 14,000 rpm. The cell pellet was resuspended in 150 /~1 of 0.2 M Tris-HC1, pH 8, and subjected to three freeze-thaw cycles with vortexing after each thaw cycle. After heating at 60~ for 10 min, the extract was spun for 10 min at 4~ and the supernatant was transferred to a fresh tube. CAT activity was performed on 50/zl of the other by extraction, using n-butyryl coenzyme and xylene extraction as described in the CAT enzyme assay system protocol of Promega Biotech followed by liquid scintillation counting or by separation on TLC. Activities were adjusted for differences in the protein concentration of the extracts. Nonadherent cells were washed three times in PBS. The cell pellet was then resuspended in 1 ml of TEN buffer and the suspension was transferred to a microfuge tube and incubated at room temperature for 5 rain. The subsequent steps were the same as for adherent cells.
Results
FcTRIb Gene. While considerable structural differences characterized Fc~RII and Fc3rRIII gene families, Fc'yRI (CD64) has been considered a product of a single gene though three distinct cDNAs had been described. We isolated genomic clones by using a radiolabeled Fe~tLI eDNA (p130) as a probe. The genomic structure indicates six exons ( Fig. 1 ) that predict a polypeptide that differs from the predicted products indicated by the three published Fc~RI cDNAs. Although each extracellular (EC) domain is encoded by a distinct exon, as would be predicted for members of the Ig superfamily, there is a termination codon at bp705 in EC domain 3 that would predict a soluble form of the receptor. We have also noted that at bp565, nucleotide TG does not appear in the cDNAs but is replaced by a 6-bp ACAATA sequence in the genomic done. The net result is that the gene sequence predicts an extra in-flame amino acid, Gln. Further differences in the genomic sequence of Fc~tLI and Fc3,RIb are reflected at 6 bp within the 5' boundary of the fifth intron, as underlined in Table 1 , and several point mutations that are highlighted in Table 2 . The entire gene is interrupted by five introns that demarcate six exons (shown in Fig. 1 and Table 1 ). The first exon begins at the transcription initiation sites (see below) and encompasses the translation start site and "he putative signal peptide. Next is a small 21-bp exon followed by three extracellular Ig domain exons. The 3' UT region is encoded by the sixth exon.
The p98/X2 eDNA predicts a polypeptide that has a shorter cytoplasmic tail with a divergent sequence. We have been unable to identify the exon(s) coding for this divergent sequence. It is possible that this variant form could arise as a result of alternative splicing and that a further 3' exon(s) encodes the 12 divergent amino acids present in the shorter cytoplasmic tail of clone p98/X2.
The FcyRI Upstream Regulatory Region. We next set out to determine whether Fc'yRI mRNA was upregulated as a specific response to IFN-'y treatment (reviewed in reference 18). The underlined nucleotide (no. 887) surrounding the 3' boundary of intron V represents a substitution from A (cDNA) to G (gene) resulting in a change in the amino acid encoded from Gin to Arg (See Table 2 (21) . In addition, it appears that TNF-oe alone does not have an effect on Fc3'RI expression and does not augment the IFN-3,-dependent induction (Fig. 3 b) . This induction occurs in the presence of cyclohexamide and IFN-qr but not with cyclohexamide alone, suggesting that de novo protein synthesis is not required and that it represents an immediate early response to IFN-3, (Fig.  3 b) . Once we had confirmed that induction of Fc'yRI genes appeared to be IFN-3' specific, we set out to define the c/sacting elements that confer IFN-'y responsiveness. The sequence of the upstream region was determined (Fig. 4) and the transcription start site(s) defined. We isolated RNA from U937 myelomonocytic cells (before and after treatment) with IFN-% This mRNA was hybridized to a radiolabeled probe that spanned from + 14 to -799 bp and digested with $1 nuclease. Three protective bands that mapped to positions -97, -83, and -82 were detected upstream from the ATG (+1), when mRNA from IFN-'),-treated cells was used as a template, but not with mRNA from untreated cells or tRNA (not shown). To confirm that these protective fragments corresponded to the transcription start site of Fc"/1Llb, a primer extension analysis was performed using an N-labeled oligonucleotide from + 14 to -9 bp (not shown). Three extended fragments that were identical to those seen in the $1 protection assay were observed and are indicated in Fig. 4 . It should be noted that the transcriptional start sites for the Fc'yRIb gene are in a similar region, but are not identical to those described for the Fc3,RIa gene (20, 21) . Our results indicate that Fc3,RI transcription can be initiated at three independent start sites and that there are no canonical, TATA, or CCAAT boxes in the 5' region flanking of the transcription start sites. Due to the absence of a single defined major transcription initiation site, the numbering of nucleotide positions in the 5' flanking region was assigned on the basis of the first nucleotide of the translation start codon as + 1.
Definition of lFN-T Response Elements. Our next goal was
to explore the possibility of whether the IFN-'y response elements reside in the upstream flanking region of Fc'yR/b gene. The region from -689 to -7 derived from the 4.3-kb EcoRI genomic fragment, as described in Materials and Methods, was cloned into a BglII site of the promoterless CAT vector, pBRAMS cat I (described in Materials and Methods). When this construction was transfected into the human myelomonocytic cell line, U937, followed by overnight treatment with recombinant IFN-% a 14-fold induction of CAT activity over background was observed (not shown). To better define the gamma response region (GRR), a series of deletion constructions were prepared and defined fragments cloned into the pBRAMS cat I vector. 14-fold IFN-3,-inducible activity was observed with a fragment from -189 to -7. Further deletion to bp 128, i.e., generating a fragment from -128 to -7, resulted in a reduction in activity to sevenfold induction. The induction of the reported gene for both these constructs was observed only in myeloid cells and not in Hela cells. However, a fragment from -79 to -7 was not active in either myeloid or Hela cells, suggesting that the IFN-'y The nucleotides italicized and underlined in the cDNA sequence were found deleted in the gene. The nucleotides in bold letters and underlined were found to be inserted in the genomic sequence. * Silent substitution (Ser).
response regions resided between upstream fragment spanning from -189 to -128 and the downstream region between -128 and -79.
We next set out to better define the sequences between -189 and -79 that would be necessary and sufficient for IFN-3, responsiveness in the context of a heterologous promoter so that we could assay expression in U937 and Hela cells. Our initial attempts were complicated by the use of a vector containing the SV40 promoter, as this appeared to silence the upstream IFN-3, response region. A construct from -189 to -7 in the context of the SV40 promoter resulted in a fivefold induction after IFN-7 treatment. A further series of deletion constructs in the context of the SV40 promoter suggested that sequences contained within -104 to -78 were necessary and sufficient to account for this modest induction after IFN-3' treatment (results not shown). On the advice of Pearse et al. (21), we refocused our attention on the upstream region -169 to -128, as this region has been shown by this group to confer IFN-3' responsiveness in the context of the basal promoter and a thymidine kinase promoter. As it appeared that this region had been silenced in the context of the SV40 promoter, we prepared a construct containing an upstream sequence from -169 to -128 in pBRAMS cat 2 vector that contains the heterologous thymidine kinase promoter. We were not able to detect a 10-fold induction in reporter gene activity in U937 cells after IFN-~/ treatment. In our earlier studies we had noted a motif RGAAAAG that resembles a general IFN responsive element, RGAAACG (24) , in both the -104 to -78 as well as immediately upstream from -169. We therefore prepared a construct from -189 to -119 (nine extra downstream bases were included to maintain the correct context) in pBRAMS cat 2, and found that this construct induced 20-50-fold induction of CAT activity after treatment with IFN-3, of both Hela and U937 cells. These results suggested that this upstream region was necessary and sufficient to account for IFN-y responsiveness and, while the downstream region was active out of context, it probably is not physiologically relevant as inclusion of this region does not confer additional activity.
To better define basal promoter activity, we next prepared a construct in which -189 to -119, i.e., the IFN-3, response region was inserted into the promoterless CAT vector, and recombinant plasmid was transfected into U937 and Hda cells. The results indicate that no inducible activity was observed, suggesting that the basal mydoid promoter most likely resides between -119 and -7 (Fig. 5 A) . It should be noted that when the same upstream fragment was placed in the context of the heterologous TK promoter, maximum IFN-3~-inducible activity was observed in both U937 and Hela cells (Fig. 5 B) . Of note is that the region containing sequences from -128 to -7 resulted in a sevenfold induction after treatment ofU937 cells with IFN-3, but not Hda cells. However, when this region was placed in the context of the heterologous TK promoter, it was active in both mydoid and Hela cells. These results suggest that the basal mydoid promoter resides in the region from -128 to -7. Careful scrutiny of this region revealed that there is a 16-bp region that is precisely conserved in the 5' upstream region of the mouse ,Fcq, RIII gene (Fig. 6, A and B) as well as a potential Pu box motif. The presence of a putative Pu box (Fig. 6 ) is relevant as its recognition site for the Pu.1 protein, a transcriptional activator expressed in macrophages B cells (25) . From these findings, we have designated this region the "PIE region" for Pu.1 and IFN-y elements spanning -104 to -84.
Discuss/on
Treatment of mydoid cells with IFN-~ results in activation of effector mechanisms that include upregulation of respiratory burst activity and 20-fold induction of Fc'ytkI expression (reviewed in reference 18). The study of Fc3,RI expression therefore provides an opportunity to explore cisacting dements that confer baseline mydoid specificity as well as induction by IFN-3'. In this report we have characterized the gene structure of a second FcyRIb gene that predicts a soluble form of the receptor. We have also defined c/s-acting elements that appear to be necessary and sufficient for IFN-3' responsiveness. Not surprisingly, these c/s-acting elements most likely serve as recognition sites for several nuclear proteins whose interactions are probably critical in baseline mydoid a a g a a a g a t t t a t a a a t t a t g t a a a a t c t c c c a t a t t c a g a g c a t g a t t t t c a t a a a a a c t a t g a t t t g t a g g c t t t  c t t t c t a a a g t t t c t c c t c a c t t t a a t t t a c a a g t g a a c a a a c t g 
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CGTGTTCCAAGAGGAAACCGTAACCTTGCACTGTGAGGTGCTCCATCTGCCTGGGAGCAGCTCTACACAGTGGTTTC
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CAACTCCTGTCTGGTTTCATGTCCTTTTCTATCTGGCAGTGGGAATAATf i TTTTTAGTGAACACTGTTCTCTGGGTG
TATAACTCTTAAAGCAAATAAATGAACTGACTTCaactgggatacatttggaootgtggtcatcaaagatgacttga aatgaggcctactctaaagoattcgagctc p98/X2 transcript has complex direct repeats in the 3' region leading to speculation that this may represent a c D N A cloning artifact. The pg0/p130 share identity up to the 19th amino acid of the cytoplasmic tail and thereafter diverge (19) . The p90 transcripts predict another 12 amino acids vs. 42 extra amino acids in p130. This difference may he accounted for by alternative splicing and there appears to be a cryptic splice donor site at the point where the sequences diverge. The presence of multiple differences in the three transcripts isolated from the same patient led Allen and Seed (19) to raise the possibility for another FcyRI gene. Van der Winkel et al. (20) have provided very compelling evidence to support this conclusion based on a Southern blot analysis of genomic D N A from three randomly selected individuals. These results suggested the existence of a second Fc~/RI gene that lacks one of the two internal HindlII sites. The gene structure represents this second gene in that we show that the lack of the HindlII site is a result of a point mutation in the second intron (Fig. 2) , as well as several other differences in the exon sequence. Our genomic analysis predicts insertion of an extra amino acid in exon 2 as a result ofa GT deletion and ACAATA insertion (Table 2) in the genomic sequence, and therefore predicts a protein sequence of SQYTV genomic vs. SVTV for the eDNA. At position 706, a C to T change predicts a termination codon and therefore predicts a soluble form of the receptor. Northern blot analysis revealed two IFN-3`-inducible transcripts (Fig. 3) , further supporting the existence of the alternative form of the gene. Several differences in nudeotide sequence of the Fc3`RIb gene and the p130 cDNA have been highlighted in Table 2 . It seems likely that the diversity in the coding and the noncoding region represents differences between two highly homologous genes as well as polymorphism within these genes. In fact, recent findings by Ernst et al. (26) confirm the existence of this Fc3`RIb and describe the presence of a third Fc3`RI gene. It therefore appears that FcyPd, like the other Fc receptors, is part of a multi-gene family. The characterization of a soluble form of Fc3`tLIb, its gene product, and its physiology role remain to be determined.
Our results indicate that sequences contained in the region from -189 to -119 are necessary and sui~cient to confer IFN-3` responsiveness. Pearse et al. (21) have illustrated in the Fc3`KIa gene, promoter sequences from -169 to -128 as the GRK and have highlighted homologues with elements that are represented in the promoters of MHC class II genes that appear necessary for basal expression as well as IFN-3` responsiveness. These c/s-acting elements include X, H and 3'-IRE box motifs (17) , and their precise role in mediating IFN-3' responsiveness in the context of the Fc3'RI genes remains to be determined, especially as our results indicate that the FeTKI gene family response to IFN-3` is cycloheximide insensitive (Fig. 3) , whereas the IFN-3`-dependent upregulation of MHC class II genes requires new protein synthesis (17) . Our results indicate the importance of another motif, RGAAAAG, that is represented in upstream region -189 to -169 and in downstream region -113 to -104, and -95 to -84, and its inclusion confers enhanced IFN-3` responsiveness (Fig, 6 A) . Of interest is that this motif is similar to a general IFN response element, GAAACG, which is found in the promoters of IFN-responsive genes and appears as a c/s-acting element of HSV immediate early genes (24) . It is interesting to note that IFN-c~ treatment impeded transcription of HSV-1 IE genes, and we postulate that the squelching effects observed after IFN-3` treatment, which we observed in the context of the SV40 promoter, may occur by a similar mechanism.
It is likely that myeloid specificity is determined in large part by the basal promoter. In this regard, it is important to note that in the absence of a heterologous promoter, both the GRR and PIE regions function only in myeloid cells. The identification of a potential Pu box is relevant, as Pu.1 proteins appear to be important partly in determining myeloidspecific gene expression (25) . The absence of canonical TATA and CAT boxes led us to define a 14-bp palindromic sequence beginning at position -80, 2 bp downstream from the most 3' transcription start site (Fig. 6) . The sequences closely resembles the initiator sequence that appears to be both necessary and su~dent for basal transcription of the terminal deoxynucleotidyl transferase gene (27) , adeno-associated virus type 2 P5 promoter (28) , and the human leukocyte IFN gene (hLelF) (29) . The initiator sequence in these genes has been shown to mediate transcription by binding to the YY1 protein, which appears to direct the transcription machinery in the absence of TATA elements (30, 31) . The importance of the initiator element in basal and tissue-specific transcription of the Fc3,RI gene remains an open and interesting question.
